CRGX (Cargo Therapeutics) Short-Term Capital Lease Obligation : $2.50 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics Short-Term Capital Lease Obligation?

Cargo Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $2.50 Mil.

Cargo Therapeutics's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 ($0.14 Mil) to Dec. 2024 ($0.63 Mil) and increased from Dec. 2024 ($0.63 Mil) to Mar. 2025 ($2.50 Mil).

Cargo Therapeutics's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($1.01 Mil) to Dec. 2023 ($2.28 Mil) but then declined from Dec. 2023 ($2.28 Mil) to Dec. 2024 ($0.63 Mil).

Cargo Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Cargo Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cargo Therapeutics Short-Term Capital Lease Obligation Chart

Cargo Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

0.94

1.01

2.28

0.63

Cargo Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial							1.64	0.65	0.14	0.63	2.50

Cargo Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Cargo Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cargo Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cargo Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070

Website

https://www.cargo-tx.com

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.